nicotinamide mononucleotide has been researched along with Cardiac Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Li, J; Lin, Q; Liu, N; Liu, Q; Tu, T; Wu, K; Xiao, Y; Xu, W; Zhang, B; Zuo, W | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Cardiac Diseases
| Article | Year |
|---|---|
Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation.
Topics: Acetylation; Animals; Cardiotonic Agents; Fibrosis; Heart Diseases; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Nicotinamide Mononucleotide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Smad3 Protein | 2021 |